Company: LGN
Filing Date: 2025-12-09
Form Type: S-1
Source: 0001193125-25-312729
Chunk: 59

Company: Legence Corp.
Filing Date: 2025-12-09
Form: S-1
Chunk 59
---
, which could adversely affect the price of our Class A Common Stock and the future business and financial results of the Company.

The Bowers acquisition is subject to the receipt of regulatory approvals and the satisfaction or waiver of other closing conditions. We cannot
provide any assurance that all necessary regulatory approvals will be obtained, as to the timing of such regulatory approvals or that the political and regulatory environment will not make such reviews longer and more uncertain, nor can we provide
any assurance that all of the other closing conditions will be satisfied or waived. The failure to obtain necessary regulatory approvals or the failure to satisfy some or delay in obtaining, all of the other required conditions could delay the
completion of the acquisition, require it to be modified or prevent it from occurring.

We believe that there are
significant benefits that may be realized through the acquisition of Bowers, and we have made certain assumptions relating to the proposed transaction, which assumptions involve significant judgement and may not reflect the full range of
uncertainties and unpredictable outcomes inherent in the transaction. These assumptions relate to numerous matters, including: projections of future revenue and our earnings per share; projections of future expenses and expense allocation relating
to the transaction; our ability to realize the expected benefits of the transaction; unknown or contingent liabilities associated with the transaction; our ability to maintain, develop and deepen relationships with employees and customers associated
with Bowers; the amount of goodwill and intangibles that will result from the transaction; other purchase accounting adjustments that we may record in our financial statements in connection with the transaction; acquisition and integration costs,
including restructuring charges and transaction costs; the impact of the financing of the transaction on our operating results or financial condition; and other financial and strategic risks of the transaction. In addition, final allocation of the
purchase price will be based upon the actual purchase price and the fair value of the assets and liabilities of Bowers as of the closing date of the transaction. Furthermore, subsequent to the closing date of the transaction, there may be further
refinements of the purchase price allocation as additional information becomes available. Pro forma financial information to be filed within 75 days after the closing of the acquisition will reflect purchase accounting, expense allocation and other
adjustments and such

36

adjustments may be material. Once the financial results of Bowers have been included in our financial results, our financial statements will differ significantly from our historical financial statements included herein. The full benefits of the Bowers acquisition, including the anticipated growth opportunities, may not be realized as expected or may not be achieved